Thrombolysis using recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest

Resuscitation. 2002 Mar;52(3):308-9. doi: 10.1016/s0300-9572(01)00489-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiopulmonary Resuscitation*
  • Emergency Medical Services*
  • Heart Arrest / therapy*
  • Hemorrhage / chemically induced
  • Humans
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator